Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity.
Wyndaele
J J
JJ
University Hospital of Antwerp, Edegem, Belgium.
Van Dromme
S A
SA
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018908:Muscle Weakness / Q000139:chemically induced* / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000503:physiopathology; D010243:Paralysis / Q000150:complications* / Q000209:etiology / Q000503:physiopathology; D013119:Spinal Cord Injuries / Q000150:complications* / Q000503:physiopathology; D001743:Urinary Bladder / Q000187:drug effects / Q000294:innervation / Q000503:physiopathology; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D019274:Botulinum Toxins, Type A